Founded in 22nd December 1965, Adimmune Corporation principally engages in R&D, manufacture and sale of vaccines and medicines. Production base is in Tanzi, Taichun. The important well-known product is H1N1 vaccine. IPO issued in Forth January 2010. Our main product is the influenza vaccine. The main product of this company, influenza vaccine, is provided to public in Taiwan by Sanofi-Aventis, Novartis and Glaxo Smith Kline (GSK). Major raw materials are the liquid, syringes, and mice. At present, source of supply is stable. Main supplier is Kitasato Institute, the American Royal will and so on. The main sales target is the Department of Health Disease Control in Executive Ministry.
Headquarters
No.3, Sec. 1, Tanxing Rd., Tanzi Township
Taichung City; Taichung City;
Contact Details: Purchase the Adimmune Corporation report to view the information.
Website: http://www.adimmune.com.tw
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service